FASEB BioAdvances (Oct 2021)

Nerve density in cancer: Less is better

  • Ligia B. Schmitd,
  • Cindy Perez‐Pacheco,
  • Nisha J. D'Silva

DOI
https://doi.org/10.1096/fba.2021-00046
Journal volume & issue
Vol. 3, no. 10
pp. 773 – 786

Abstract

Read online

Abstract The density of nerves in cancer is emerging as a relevant clinical parameter for patient survival. Nerves in the tumor microenvironment have been associated with poor survival and recurrence, particularly if involved in perineural invasion. However, usually only a few nerves inside a tumor are affected by perineural invasion, while most nerves are not. Mechanistic studies have shown nerve‐secreted factors promote tumor growth and invasion thereby making tumors more aggressive. Therefore, the overall number of nerves in the tumor microenvironment should be more representative of the nerve‐tumor biological interaction than perineural invasion. This review summarizes the available clinical information about nerve density as a measure of clinical outcome in cancer and explores the mechanisms underlying nerve density in cancer, specifically, neurogenesis, axonogenesis, and neurotropism.

Keywords